No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CYRX240719C7500
- 0.21
- +0.16+320.00%
15min DelayClose Jul 11 16:00 ET
0.25High0.05Low
0.06Open0.05Pre Close527 Volume1.04K Open Interest7.50Strike Price6.27KTurnover85.01%IV9.67%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.21Extrinsic Value100Contract SizeAmericanOptions Type0.3265Delta0.4127Gamma40.17Leverage Ratio-0.0210Theta0.0005Rho13.12Eff Leverage0.0037Vega
Intraday
- 5D
- Daily
News
CryoPort (CYRX) Moves 26.7% Higher: Will This Strength Last?
CryoPort, Inc. (CYRX Quick QuoteCYRX - Free Report) shares ended the last trading session 26.7% higher at $7.03.
CryoPort Up Over 25%, On Track for Largest Percent Increase Since November 2022 -- Data Talk
CryoPort, Inc. ( CYRX ) is currently at $6.96, up $1.41 or 25.32% --Would be highest close since June 26, 2024, when it closed at $7.10 --On pace for largest percent increase since Nov. 10, 2022,
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Helen of Troy Limited (NASDAQ:HELE) fell sharply during Tuesday's session after the company reported soft first-quarter earnings and lowered its FY25 guidance.Helen of Troy reported
CryoPort (CYRX) Loses -43.56% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner
It's Down 28% But Cryoport, Inc. (NASDAQ:CYRX) Could Be Riskier Than It Looks
To the annoyance of some shareholders, Cryoport, Inc. (NASDAQ:CYRX) shares are down a considerable 28% in the last month, which continues a horrid run for the company. The recent drop completes a d
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Monday.Shares of ResMed Inc. (NYSE:RMD) fell sharply during Monday's session following sleep apnea data from Lilly.Citigro
Comments
Despite Cryoport's superior revenue outlook, its P/S ratio is not reflecting this positive outlook, suggesting that the market may be pricing in some risks. If the analysts' forecasts are accurate, the stock could be undervalued at its current price.
Cryoport, Inc.'s (NASDAQ:CYRX) Shares Not Telling The Full StoryInsider selling at Cryoport, Inc. over the past year, especially in recent months, may worry shareholders. However, significant insider ownership indicates alignment with other shareholders. The absence of insider buying in the last three months is noteworthy.
Cryoport's debt levels appear manageable, given healthy cash reserves and short-term assets. However, meeting future obligations will hinge on its profitability, an area where the company's performance has faltered. Cryoport saw modest revenue growth and a cash outflow last year.
$AMN Healthcare Services(AMN.US$ $CBL International(BANL.US$ $Chanson International(CHSN.US$ $Cryoport(CYRX.US$ $MetLife(MET.US$ $MillerKnoll(MLKN.US$ $Nova Lifestyle(NVFY.US$ $InspireMD(NSPR.US$ $Paramount Global-B(PARA.US$ $Ryder System(R.US$ $Recursion Pharmaceuticals(RXRX.US$ $Silk Road Medical(SILK.US$ $60 Degrees Pharmaceuticals(SXTP.US$ $Uber Technologies(UBER.US$ $Victory Capital(VCTR.US$
1
Read more